Abstract
Terminalia belerica Roxb. fruits have been previously reported against diabetes, ulcer, microbial problems and hepatotoxicity. The present study was aimed to investigate antioxidant and anticancer potential of sequentially fractionated hexane (TBHE), chloroform (TBCE), ethyl acetate (TBEE), butanol (TBBE) and water (TBWE) extracts from the 70% methanolic extract of T. belerica fruits. TBCE, TBEE, TBBE and TBWE showed excellent ROS (reactive oxygen species) and RNS (reactive nitrogen species) scavenging activities which was investigated using 11 different assays for various free radicals. Among 5 fractions, TBHE and TBCE remained nontoxic to any of the malignant cell lines including normal cells (WI-38). TBBE and TBWE inhibited the proliferation of breast (MCF-7), cervical (HeLa) and brain (U87) cancer cells by inducing G2/M arrest while TBEE caused apoptosis. However, these fractions did not inhibit the proliferation of lung (A549) and liver (HepG2) cancer cells. BrdU incorporation study also suggested the efficient anticancer potential of TBEE, TBBE and TBWE. Moreover, TBBE and TBWE treated MCF-7, HeLa and U87 cells showed upregulation of p53 and p21 proteins. Phytochemical analysis reflected the presence of adequate quantities of different phytochemicals. Moreover, HPLC analysis show peaks of purpurin, catechin, tannic acid, reserpine, ellagic acid, methyl gallate, aconitine and rutin in TBBE, TBWE and TBEE. Hence these polar extracts of T. belerica can be used to develop drug against different types of cancer.
Similar content being viewed by others
References
Agarwal ML, Agarwal A, Taylor WR et al (1998) A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proc Natl Acad Sci USA 95:14775–14778
Anand KK, Singh B, Saxena AK et al (1997) 3, 4, 5-trihydroxy benzoic acid (Gallic acid), the hepatoprotective principle in the fruits of Terminalia bellerica bioassay guided activity. Pharmacol Res 36:315–321
Aruoma OI, Halliwell B, Hoey BM et al (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Rad Biol Med 6:593–597
Buxton EJ, Meanwell CA, Hilton C et al (1989) Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst 81:359–361
Chao JI, Kuo PC, Hsu TS (2004) Down-regulation of survivin in nitric oxide induced cell growth inhibition and apoptosis of the human lung carcinoma cells. J Biol Chem 279:20267–20276
Christiansen S, Autschbach R (2006) Doxorubicin in experimental and clinical heart failure. Eur J Cardiothorac Surg 30:611–616
Cook NC, Samman S (1996) Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. Nutr Biochem 7:66–76
Das A, Chaudhuri D, Mandal N et al (2012) Study of antioxidant and reactive oxygen species scavenging activity of the edible tuber of “greater yam” (Dioscorea alata L.) from north-east India. Asian J Pharm Clin Res 5:74–84
Elizabeth KM (2005) Antimicrobial activity of Terminalia bellerica. Indian J Clin Biochem 20:150–153
Fragkos M, Jurvansuu J, Beard P (2009) H2AX is required for cell cycle arrest via the p53/p21 pathway. Mol Cell Biol 29:2828–2840
Ghate NB, Chaudhuri D, Sarkar R et al (2013) An antioxidant extract of tropical lichen, Parmotrema reticulatum, induces cell cycle arrest and apoptosis in breast carcinoma cell line MCF-7. PLoS ONE 8:e82293. doi:10.1371/journal.pone.0082293
Ghate NB, Hazra B, Sarkar R et al (2014a) In vitro anticancer activity of Spondias pinnata bark on human lung and breast carcinoma. Cytotechnology 66:209–218
Ghate NB, Hazra B, Sarkar R et al (2014b) Alteration of Bax/Bcl-2 ratio contributes to Terminalia belerica induced apoptosis in human lung and breast carcinoma. In Vitro Cell Dev Biol Anim 50:527–537
Giaccone G, Herbst RS, Manegold C et al (2004) Gefitinib in combination with gemcitabine and cisplatin in advanced non–small-cell lung cancer: a phase III trial—INTACT 1. J Clin Oncol 2:777–784
Gokhale SB, Kokate CK, Purohit AP (2003) Pharmacognosy. Nirali Prakashan, Pune
Halliwell B (1991) Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 91:S14–S22
Han YH, Park WH (2009) Growth inhibition in antimycin A treated-lung cancer Calu-6 cells via inducing a G1 phase arrest and apoptosis. Lung Cancer 65:150–160
Harbornen JB, Baxter H (1995) Phytochemical dictionary: a handbook of bioactive compounds from plants. Taylor and Francis, London
Hazra B, Biswas S, Mandal N (2008) Antioxidant and free radical scavenging activity of Spondias pinnata. BMC Complement Altern Med 8:63. doi:10.1186/1472-6882-8-63
Hazra B, Sarkar R, Biswas S et al (2010) Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis. BMC Complement Altern Med 10:20. doi:10.1186/1472-6882-10-20
Kang KH, Kim WH, Choi KH (1999) p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells. Exp Cell Res 253:403–412
Kao GD, McKenna WG, Yen TJ (2001) Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells. Oncogene 20:3486–3496
Kochevar EI, Redmond WR (2000) Photosensitized production of singlet oxygen. Methods Enzymol 319:20–28
Kohen R, Nyska A (2002) Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30:620–650
Kumudhavalli MV, Vyas M, Jayakar B (2010) Phytochemical and pharmacological evaluation of the plant fruit of Terminalia belerica Roxb. Int J Pharm Life Sci 1:1–11
Lakin ND, Jackson SP (1999) Regulation of p53 in response to DNA damage. Oncogene 18:7644–7655
Levine A (1997) p53 the cellular gatekeeper for growth and division. Cell 88:323–331
Lin YJ, Liu YS, Yeh HH et al (2012) Selfassembled poly (e-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells. Int J Nanomed 7:4169–4183
Lissi EA, Modak B, Torres R et al (1999) Total antioxidant potential of resinous exudates from Heliotropium species, and a comparison of the ABTS and DPPH methods. Free Rad Res 30:471–477
Lukas J, Lukas C, Bartek J (2004) Mammalian cell cycle checkpoints: signaling pathways and their organization in space and time. DNA Repair 3:997–1007
Moldovan GL, Pfander B, Jentsch S (2007) PCNA, the maestro of the replication fork. Cell 129:665–679
O’Loughlin C, Heenan M, Coyle S et al (2000) Altered cell cycle response of drug-resistant lung carcinoma cells to doxorubicin. Eur J Can 36:1149–1160
Rice-Evans CA, Miller NJ, Bolwell PG et al (1995) The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Rad Res 22:375–383
Roninson IB (2002) Oncogenic functions of tumour suppressor p21Waf1/Cip1/Sdi1: association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179:1–14
Saroya AS (2011) Herbalism phytochemistry and ethanopharmacology. Science Publishers, Enfield, pp 357–361
Stief TW (2003) The physiology and pharmacology of single oxygen. Med Hypotheses 60:567–572
Su D, Cheng Y, Liu M et al (2013) Comparision of piceid and resveratrol in antioxidation and antiproliferation activities in vitro. PLoS ONE 8:e54505. doi:10.1371/journal.pone.0054505
Tam K (2013) The roles of doxorubicin in hepatocellular carcinoma. ADMET DMPK 1:29–44
Tyagi AK, Singh RP, Agarwal C et al (2002) Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. Clin Can Res 8:3512–3519
Tylor BS, Kion YM, Wang QI et al (1997) Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch Surg 132:1177–1183
Von Hoff DD, Layard MW, Basa P et al (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710–717
Yildirim A, Mavi A, Kara AA (2001) Determination of antioxidant and antimicrobial activities of Rumex crispus L. extracts. J Agric Food Chem 49:4083–4089
Acknowledgements
The authors are thankful to Mr. Ranjit Kumar Das, Mr. Pradip Kumar Mallik and Mr. Ranjan Dutta for their technical assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declared no conflict of interest.
Additional information
Tapasree Basu and Sourav Panja have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Basu, T., Panja, S., Ghate, N.B. et al. Antioxidant and antiproliferative effects of different solvent fractions from Terminalia belerica Roxb. fruit on various cancer cells. Cytotechnology 69, 201–216 (2017). https://doi.org/10.1007/s10616-016-0051-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-016-0051-6